Absci Corp at Cantor Fitzgerald Global Healthcare Conference Transcript
Good morning, everyone, and thank you for joining. My name is Ross Osborn. I'm the medtech, life science tools, and diagnostics analyst at Cantor. And today, we are joined by Absci Corporation with Alex Kahn, VP of Finance and Head of Investor Relations.
Questions & Answers
So Alex, would you just provide a brief overview of your Company and yourself for those less familiar with the story?
Greg. Thank you, Ross, and thank you to Cantor for the opportunity to be here today. And we appreciate it.
So at Absci, we're merging AI with scalable wet lab technologies with a mission to create better biologics for patients faster. And the company that we are today is fundamentally different than where we were at our founding. And even for those who knew us around the time of the IPO, we really evolved a lot since then.
So at our founding, our Founder and CEO,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
